99 related articles for article (PubMed ID: 10395747)
1. Peptide aldehyde inhibitors of bacterial peptide deformylases.
Durand DJ; Gordon Green B; O'Connell JF; Grant SK
Arch Biochem Biophys; 1999 Jul; 367(2):297-302. PubMed ID: 10395747
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
Green BG; Toney JH; Kozarich JW; Grant SK
Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.
Rajagopalan PT; Grimme S; Pei D
Biochemistry; 2000 Feb; 39(4):779-90. PubMed ID: 10651644
[TBL] [Abstract][Full Text] [Related]
5. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human peptide deformylase: implications for antibacterial drug design.
Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
[TBL] [Abstract][Full Text] [Related]
7. Novel nonpeptidic inhibitors of peptide deformylase.
Jayasekera MM; Kendall A; Shammas R; Dermyer M; Tomala M; Shapiro MA; Holler TP
Arch Biochem Biophys; 2000 Sep; 381(2):313-6. PubMed ID: 11032420
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.
Meinnel T; Lazennec C; Villoing S; Blanquet S
J Mol Biol; 1997 Apr; 267(3):749-61. PubMed ID: 9126850
[TBL] [Abstract][Full Text] [Related]
9. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
10. Purification, characterization, and inhibition of peptide deformylase from Escherichia coli.
Rajagopalan PT; Datta A; Pei D
Biochemistry; 1997 Nov; 36(45):13910-8. PubMed ID: 9374870
[TBL] [Abstract][Full Text] [Related]
11. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
[TBL] [Abstract][Full Text] [Related]
12. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
[TBL] [Abstract][Full Text] [Related]
13. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
15. YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases.
Haas M; Beyer D; Gahlmann R; Freiberg C
Microbiology (Reading); 2001 Jul; 147(Pt 7):1783-1791. PubMed ID: 11429456
[TBL] [Abstract][Full Text] [Related]
16. Control of peptide deformylase activity by metal cations.
Ragusa S; Blanquet S; Meinnel T
J Mol Biol; 1998 Jul; 280(3):515-23. PubMed ID: 9665853
[TBL] [Abstract][Full Text] [Related]
17. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
[TBL] [Abstract][Full Text] [Related]
18. A direct spectrophotometric assay for peptide deformylase.
Guo XC; Ravi Rajagopalan PT; Pei D
Anal Biochem; 1999 Sep; 273(2):298-304. PubMed ID: 10469501
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum.
Bracchi-Ricard V; Nguyen KT; Zhou Y; Rajagopalan PT; Chakrabarti D; Pei D
Arch Biochem Biophys; 2001 Dec; 396(2):162-70. PubMed ID: 11747293
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.
Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
